Patent details

Basic Information

Publication number:

EP3512525

PCT Application Number:

US2017051723

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP178515847

PCT Publication Number:

WO2018053232

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATION THERAPY WITH LIPOSOMAL ANTISENSE OLIGONUCLEOTIDES

French Title of Invention:

PHYTOTHÉRAPIE AVEC DES OLIGONUCLÉOTIDES ANTISENS LIPOSOMAUX

German Title of Invention:

KOMBINATIONSTHERAPIE MIT LIPOSOMALEN ANTISENSE-OLIGONUKLEOTIDEN

SPC Number:

Dates

Filing date:

15/09/2017

Grant date:

27/07/2022

EP Publication Date:

24/07/2019

PCT Publication Date:

22/03/2018

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

27/07/2022

EP B1 Publication Date:

27/07/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

15/09/2022

Expiration date:

15/09/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

20/07/2022

 

 

Name:

Bio-Path Holdings, Inc.

Address:

4710 Bellaire Boulevard Suite 210, Bellaire, TX 77401, United States (US)

Inventor

Name:

ASHIZAWA, Ana Tari

Address:

United States (US)

Priority

1

Priority Number:

201662395680 P

Priority Date:

16/09/2016

Priority Country:

United States (US)

2

Priority Number:

201762487277 P

Priority Date:

19/04/2017

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/7088; A61K 31/711; A61P 35/02;

Publication

European Patent Bulletin

Issue number:

202230

Publication date:

27/07/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages